Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Ann Surg. 2020 Nov 17;276(5):e474–e482. doi: 10.1097/SLA.0000000000004613

Figure 4:

Figure 4:

Stratification of overall survival analysis in patients with initially unresectable colorectal liver metastases who received hepatic arterial infusion and systemic chemotherapy (n=128) by presence or absence of alterations in: A. BRAF only; B. RTK-RAS signaling pathway; C. RAS/RAF-TP53 co-alteration; D. BRAF-TP53 co-alteration. Number at risk at each time point indicated in adjoining risk table.